TipRanks
Wai Yuen Tong Medicine Holdings Limited (HK:0897)
:0897
Hong Kong Market
0897
Wai Yuen Tong Medicine Holdings Limited
RESEARCH TOOLSreports
Want to see HK:0897 full AI Analyst Report?

Wai Yuen Tong Medicine Holdings Limited (0897) Ratios

2 Followers

Wai Yuen Tong Medicine Holdings Limited Ratios

HK:0897's free cash flow for Q4 2025 was HK$0.55. For the 2025 fiscal year, HK:0897's free cash flow was decreased by HK$ and operating cash flow was HK
lt;0.01. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 1.40 1.40 1.73 2.18 1.63
Quick Ratio
 0.87 0.87 1.07 1.37 0.64
Cash Ratio
 0.31 0.31 0.37 0.41 0.34
Solvency Ratio
 0.14 0.20 0.18 0.10 0.02
Operating Cash Flow Ratio
 0.23 0.16 0.29 0.50 0.06
Short-Term Operating Cash Flow Coverage
 0.36 0.25 0.55 1.04 0.15
Net Current Asset Value
HK$ 152.65MHK$ 152.65MHK$ 65.34MHK$ 120.57MHK$ -631.31M
Leverage Ratios
Debt-to-Assets Ratio
 0.17 0.17 0.25 0.27 0.25
Debt-to-Equity Ratio
 0.24 0.24 0.37 0.40 0.75
Debt-to-Capital Ratio
 0.19 0.19 0.27 0.29 0.43
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.12 0.17 0.31
Financial Leverage Ratio
 1.38 1.38 1.47 1.51 2.99
Debt Service Coverage Ratio
 0.14 0.23 0.58 0.54 0.20
Interest Coverage Ratio
 -0.92 -0.97 -1.13 1.00 1.75
Debt to Market Cap
 0.67 0.75 0.85 1.59 3.76
Interest Debt Per Share
 0.27 0.26 0.41 0.51 1.48
Net Debt to EBITDA
 3.40 2.18 2.47 3.48 10.30
Profitability Margins
Gross Profit Margin
52.96%52.96%50.51%50.37%47.38%
EBIT Margin
-2.36%-2.50%4.32%3.46%1.61%
EBITDA Margin
6.28%9.81%16.47%14.84%9.01%
Operating Profit Margin
-2.36%-2.50%-4.25%5.22%4.01%
Pretax Profit Margin
0.53%0.53%0.55%-1.74%-1.16%
Net Profit Margin
0.58%0.58%0.95%-1.96%-1.59%
Continuous Operations Profit Margin
0.60%0.60%0.95%-0.93%0.58%
Net Income Per EBT
109.94%109.94%174.23%112.64%137.85%
EBT Per EBIT
-22.48%-21.23%-12.85%-33.35%-28.87%
Return on Assets (ROA)
0.25%0.25%0.41%-0.73%-0.29%
Return on Equity (ROE)
0.34%0.34%0.60%-1.11%-0.87%
Return on Capital Employed (ROCE)
-1.35%-1.43%-2.30%2.38%0.96%
Return on Invested Capital (ROIC)
-1.07%-1.16%-1.91%1.09%-0.02%
Return on Tangible Assets
0.25%0.25%0.41%-0.73%-0.29%
Earnings Yield
0.96%1.08%1.75%-5.28%-4.69%
Efficiency Ratios
Receivables Turnover
 4.19 4.19 3.80 3.62 6.59
Payables Turnover
 15.11 15.11 20.19 14.83 8.52
Inventory Turnover
 1.42 1.42 1.55 1.26 0.41
Fixed Asset Turnover
 1.21 1.21 1.17 1.18 1.34
Asset Turnover
 0.42 0.42 0.43 0.37 0.18
Working Capital Turnover Ratio
 4.52 3.16 2.10 1.05 1.27
Cash Conversion Cycle
 320.24 320.24 313.69 365.34 895.06
Days of Sales Outstanding
 87.21 87.21 96.15 100.92 55.42
Days of Inventory Outstanding
 257.18 257.18 235.62 289.04 882.51
Days of Payables Outstanding
 24.15 24.15 18.08 24.62 42.86
Operating Cycle
 344.39 344.39 331.77 389.96 937.93
Cash Flow Ratios
Operating Cash Flow Per Share
 0.09 0.06 0.09 0.16 0.08
Free Cash Flow Per Share
 0.08 0.05 0.07 0.13 0.05
CapEx Per Share
 0.01 0.01 0.02 0.03 0.03
Free Cash Flow to Operating Cash Flow
 0.86 0.81 0.73 0.82 0.63
Dividend Paid and CapEx Coverage Ratio
 7.39 5.22 0.45 5.53 2.74
Capital Expenditure Coverage Ratio
 7.39 5.22 3.77 5.53 2.74
Operating Cash Flow Coverage Ratio
 0.36 0.25 0.23 0.34 0.05
Operating Cash Flow to Sales Ratio
 0.15 0.10 0.14 0.24 0.07
Free Cash Flow Yield
20.63%15.34%18.54%54.04%13.28%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 104.17 91.67 57.14 -18.92 -21.34
Price-to-Sales (P/S) Ratio
 0.61 0.54 0.54 0.37 0.34
Price-to-Book (P/B) Ratio
 0.35 0.31 0.34 0.21 0.19
Price-to-Free Cash Flow (P/FCF) Ratio
 4.85 6.52 5.39 1.85 7.53
Price-to-Operating Cash Flow Ratio
 4.17 5.27 3.96 1.52 4.78
Price-to-Earnings Growth (PEG) Ratio
 -0.19 -2.14 -0.38 0.82 0.26
Price-to-Fair Value
 0.35 0.31 0.34 0.21 0.19
Enterprise Value Multiple
 13.13 7.71 5.77 5.98 14.07
Enterprise Value
 563.90M 517.23M 708.39M 695.71M 1.63B
EV to EBITDA
 13.13 7.71 5.77 5.98 14.07
EV to Sales
 0.83 0.76 0.95 0.89 1.27
EV to Free Cash Flow
 6.54 9.08 9.43 4.43 28.06
EV to Operating Cash Flow
 5.66 7.34 6.92 3.63 17.81
Tangible Book Value Per Share
 1.06 1.05 1.05 1.17 3.03
Shareholders’ Equity Per Share
 1.07 1.05 1.05 1.17 1.93
Tax and Other Ratios
Effective Tax Rate
 0.02 -0.12 -0.74 0.47 1.03
Revenue Per Share
 0.62 0.61 0.66 0.66 1.06
Net Income Per Share
 <0.01 <0.01 <0.01 -0.01 -0.02
Tax Burden
 1.10 1.10 1.74 1.13 1.38
Interest Burden
 -0.22 -0.21 0.13 -0.50 -0.72
Research & Development to Revenue
 0.00 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
 0.55 0.55 0.55 0.14 0.08
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 <0.01 <0.01
Income Quality
 24.98 19.40 25.11 3.86 -4.46
Currency in HKD